This is further affirmed by the findings that genetic depletion of mouse mast cell protease 4—presumably responsible for endogenous IGF-1 degradation—alleviated myocardial infarct size, post-ischemic cardiac dysfunction and remodeling [162]. The gene discussed is IGF1; the disease is myocardial infarction.